7 Results (Page 1 of 1)
China Free Sample Markets Research Reports
China Biosimilars Market Analysis Sample Report
China's biosimilars market size was valued at $1.54 Bn in 2022 and is estimated to expand at a CAGR of 23.7% from 2022 to 2030 and will reach $8.46 Bn in 2030. The market is segmented by product type and indication type. The China Biosimilars market will grow as China biosimilar market is driven by its cost-effective manufacturing capabilities. The key market players are Bio-Thera Solutions (CHN), Innovent Biologics (CHN), Shanghai Henlius Biotech (CHN), MabSpace Biosciences Co. (CHN), and others.
China Antiepileptics Drugs Market Analysis Sample Report
The China antiepileptics drugs market stood at around $0.82 Bn in 2022 and is projected to reach $1.32 Bn in 2030 with a CAGR of 2.3% for the year 2022-2030. Valproic acid and Lamotrigine are the top selling antiepileptic drugs in China. The market is segmented by generation and by distribution channel.
China Dermatology Therapeutics Market Analysis Sample Report
The China dermatology therapeutics market is projected to grow from $2.79 Bn in 2022 to $5.96 Bn in 2030 with a CAGR of 9.94% for the year 2022-2030. As China is one of the countries with a lot of focus on skin-related disorders and skincare routines, the market is projected to grow during the forecast period.
China Psoriasis Market Analysis Sample Report
The increase in healthcare expenditure and the introduction of novel treatments for psoriasis in China are causing the China psoriasis market to grow during the forecast period. Major diseases in China include plaque psoriasis, nail psoriasis, and guttate psoriasis. The market is segmented by drug class, distribution channel, and route of administration.
China Telemedicine Market Analysis Sample Report
The China telemedicine market is expected to witness growth from $4.88 Bn in 2022 to $20.59 Bn in 2030 with a CAGR of 19.7% for the year 2022-2030. China shows a lot of potential for the growth of telemedicine providers in the country. The market is segmented by products and services, type, specialty, and by delivery mode.
China Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Sample Report
China Paroxysmal Nocturnal Hemoglobinuria (PNH) therapeutics market is growing due to the increased cases of PNH cases in China. Although being a rare disease, its prevalence in China and the increased adoption of novel therapeutics to treat PNH are the major market drivers of the China PNH therapeutics market.
China Nutritional Supplements Market Analysis Sample Report
By 2030, it is anticipated that the China nutrition and supplements market will reach a value of $65.74 Bn from $30.67 Bn in 2022, growing at a CAGR of 10% during 2022-2030. The market is primarily dominated by local players such as Health Food Company, Fancl Corporation, and CSPC Pharmaceutical Group. The market for Nutrition and supplements in China is primarily driven by government regulations, increasing customer awareness, and e-commerce platforms. The China nutrition and supplements market in China is segmented by Type, Product, application, and Distribution Channel.